Zuellig Pharma Company Profile
Zuellig Pharma is Asia Pacific's trusted pharmaceutical and healthcare distribution and logistics specialist. We combine local market expertise with modern technology to provide reliable, quality-driven distribution services. For over 60 years, we have been meeting the ever-changing needs of the marketplace through continuous innovation and open communication. Our transparent processes build trust and partnerships, allowing manufacturers to confidently focus on their own core expertise.
Taking advantage of our extensive experience and infrastructure allows each manufacturer to focus on their own core expertise. A scalable infrastructure supports the marketing efforts of our principals, and our debt collection service reduces the country risks of individual principals.
Location
19 Loyang Way #08-20
Singapore
508724
Singapore
Contact
Phone: 65-65468188
Fax: 65-6548288
Email: enquiry@zuelligpharma.com.sg
News Articles
UPDATE 1-Zuellig to take 40 pct of NZ's Ebos in pharmaceutical buyout
WELLINGTON, May 29 (Reuters) - Hong Kong-based Zuellig Group will take a 40 percent stake in New Zealand pharmaceutical and veterinary goods company Ebos Group Ltd, which is buying its Australian phar...
NZ's Ebos to buy Australian pharmaceutical wholesaler
WELLINGTON, May 29 (Reuters) - New Zealand pharmaceutical and veterinary goods company Ebos Ltd said on Wednesday it would buy Australian pharmaceutical wholesaler and distributor Zuellig Healthcare,...
New Zealand's Ebos To Buy Aussie Wholesaler From Hong Kong Owner
Ebos Group plans to acquire Australia drug wholesaler Symbion for $700 million from Hong Kong's Zuellig Group in exchange for a 40% stake in the New Zealand drug maker.
Pharma 3.0 Pulls Companies into the Digital Future
Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0. Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drug...
Big pharma companies BMS and Merck are pharma partnering on Daclatasvir
Big pharma company, Bristol-Myers Squibb, is pharma partnering with another big pharma company, Merck, to develop Daclatasvir to treat Hepatitis C. The big pharma companies will work on the hepatitis...
Cardinal Health Has Acquired Six China Drug Distributors for $120 Million
Cardinal Health, a major US drug distributor, says it has spent $120 million to acquire six China drug distributors during the last year, paying less than $30 million for each one. Cardinal&rsqu...
Merck enter pharma partnering pact with Ra Pharma for cyclomimetics
Ra Pharmaceuticals has entered into a pharma partnering deal with Merck, a top 50 big pharma corporation, focused on the development of Cyclomimetics, a new class of compounds that have the diversity...
Verona Pharma plc: Analyst Presentation on the Company Website
LONDON, April 10, 2013 /PRNewswire/ -- Verona Pharma plc ("Verona Pharma" or the "Company") Verona Pharma plc (VRP: London Stock Exchange) ("Verona Pharma", or the "Company"), the biotechnology co...
Drugs and Medications
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 0.5 mg
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 1 mg
Metoprolol tartrate [Med-Health Pharma, LLC]
Metoprolol Tartrate Tablets, USP
Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )
PubMed Articles
Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...
Is pharma running out of brainy ideas?
Clinical Trials
To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.
Pharma-Pen (Formerly Innoject) Auto-Injectory TIV
The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...
To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions
To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.
This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...
Development of a New Method for Analgesia
Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.
Companies
Zuellig Pharma is Asia Pacific's trusted pharmaceutical and healthcare distribution and logistics specialist. We combine local market expertise with modern technology to provide reliable, quality-driv...
H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...
LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...
Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies,...
FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...
More Information about "Zuellig Pharma" on BioPortfolio
We have published hundreds of Zuellig Pharma news stories on BioPortfolio along with dozens of Zuellig Pharma Clinical Trials and PubMed Articles about Zuellig Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zuellig Pharma Companies in our database. You can also find out about relevant Zuellig Pharma Drugs and Medications on this site too.
